Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line CollectionKevin Kwei(Stanford University), Robert J. Pelham(RG Biopharma (United States))PLoS ONESeptember 28, 201210.1371/journal.pone.0046518Cited by 48SaveCiteExport RISWatch citationsRelated PapersSMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer|PLoS ONE|2011|49PD03-09: Breast Cancer Recurrence Risk Probed by Whole Transcriptome Next Generation Sequencing in 136 Patients.|Cancer Research|2011|0